相关实验视频

Updated: Jul 1, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

血清25-基维生素D水平和肺高血压之间的反向因果关系:一个双样本的门德尔随机化研究

Ce Chao¹, Min Wang¹, Kun Mei¹

¹Department of Cardiothoracic Surgery The Third Affiliated Hospital of Soochow University Changzhou China.

Pulmonary circulation

|March 8, 2024

概括

低维生素D水平 (25-氧维生素D) 可能因果性地增加患肺高血压 (PH) 的风险. 这一发现表明,维生素D可能是PH的潜在治疗标.

科学领域:

遗传学和流行病学
心血管研究研究心血管研究
营养科学营养科学

背景情况:

观察性研究表明25-基维生素D (25(OH) D) 与肺高血压 (PH) 之间存在关联.
血清25(OH) D水平与PH之间的因果关系尚不清楚.
了解这种关系对于确定PH的潜在治疗点至关重要.

研究的目的:

调查血清25-基维生素D (25(OH) D水平与肺高血压 (PH) 之间的潜在因果关系.
使用门德尔随机化 (MR) 来确定因果关系,克服观察性研究的局限性.

主要方法:

采用两个样本的孟德尔随机化 (MR) 设计,使用来自大型全基因组关联研究 (NHGRI-EBI Catalog和FinnGen) 的总结数据.
使用逆方差权衡 (IVW) 作为主要分析方法.
进行了敏感性分析,包括科克兰的Q测试,MR-Egger拦截和留出一个分析,以评估异质性和性.

主要成果:

在基因预测的25(OH) D水平和肺高血压 (OR:0.376,95%CI:0.162-0.876,p=2.334×10−2) 之间观察到显著的逆因果关系.
灵敏度分析表明没有显著的异质性或性质的证据,支持研究结果的稳定性.
结果表明,较低的25...OH) D水平与PH风险增加有关.

结论:

这项MR研究提供了强有力的证据,证明25-基维生素D与肺高血压之间的反向因果关系.
这些发现表明,维持足够的维生素D水平可能会对PH发育起保护作用.
这一途径需要进一步调查潜在的治疗干预措施,以控制肺高血压.

关键词:

门德尔的随机化全基因组关联研究研究.肺高血压是一种肺高血压.这是因果关系的原因.维生素D是维生素D的重要组成部分.

更多相关视频

Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice

Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice

Published on: January 16, 2013

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

相关概念视频

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

Role of Skin in Vitamin D Synthesis

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...

Hypertension and Regulation of Blood Pressure

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Causality in Epidemiology

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...